Pre-operative Window of Opportunity Study of the Effects of Atovaquone on Hypoxia in Non-small Cell Lung Carcinoma
Phase of Trial: Phase 0
Latest Information Update: 18 Apr 2017
At a glance
- Drugs Atovaquone (Primary)
- Indications Pneumocystis pneumonia
- Focus Pharmacodynamics
- Acronyms ATOM
- 12 Apr 2017 Planned End Date changed from 1 Nov 2019 to 1 Feb 2019.
- 21 Jun 2016 Status changed from not yet recruiting to recruiting.
- 22 Feb 2016 Planned End Date changed from 1 Oct 2019 to 1 Nov 2019 as reported by ClinicalTrials.gov.